tiprankstipranks
Alumis Inc. (ALMS)
NASDAQ:ALMS
US Market
ALMS
Alumis Inc.
RESEARCH TOOLSreports
Want to see ALMS full AI Analyst Report?

Alumis Inc. (ALMS) Stock News & Sentiment

339 Followers
Compelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target
Premium
Ratings
Compelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target
19d ago
ALMS
Envu’s Compelling Efficacy and Superior Safety Profile Support Buy Rating on ALMS
Premium
Ratings
Envu’s Compelling Efficacy and Superior Safety Profile Support Buy Rating on ALMS
1M ago
ALMS
Alumis Highlights Strong Phase 3 Psoriasis Results for Envudeucitinib
Premium
Company Announcements
Alumis Highlights Strong Phase 3 Psoriasis Results for Envudeucitinib
1M ago
8K
ALMS
Alumis Inc. (ALMS): Buy Rating on Envu’s Strong Phase 3 Data and Attractive Risk‑Reward Ahead of 2026 FDA Submission
Premium
Ratings
Alumis Inc. (ALMS): Buy Rating on Envu’s Strong Phase 3 Data and Attractive Risk‑Reward Ahead of 2026 FDA Submission
1M ago
ALMS
TYK2 Validation and Expanding Indications Drive Buy Rating and $40 Price Target for Alumis
Premium
Ratings
TYK2 Validation and Expanding Indications Drive Buy Rating and $40 Price Target for Alumis
2M ago
ALMS
Alumis launches sizable common stock public offering
Premium
Company Announcements
Alumis launches sizable common stock public offering
4M ago
8K
ALMS
Alumis Unveils Positive Phase 3 Data for Psoriasis Drug
Premium
Company Announcements
Alumis Unveils Positive Phase 3 Data for Psoriasis Drug
4M ago
8K
ALMS
More ALMS News >

ALMS News on the Web

Alumis Inc. Surges On Exciting Drug Breakthrough
TipRanks News
Bullish
Compelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target
TipRanks News
Bullish
Why Alumis Inc. Stock Is Dropping After Good News
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
'Best of the best': Oppenheimer says buy these 12 small- and mid-cap stocks for upside through the end of 2026
Markets Insider
Neutral
Why Alumis Inc. Shares Are Suddenly Surging
TipRanks News
Neutral
Alumis falls -16.1%
TipRanks News
Neutral
Envu’s Compelling Efficacy and Superior Safety Profile Support Buy Rating on ALMS
TipRanks News
Bullish

News Score - Last 7 Days

Positive
ALMS
Sector Average
Media Buzz
This Week2 articles
Weekly Average7.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALMS’s Media Buzz Sentiment?
2 articles about ALMS were published this week. In an average week, 7.25 articles are published.
    What is ALMS’s weekly average amount of articles?
    In an average week, 7.25 articles about ALMS are published.
      What is ALMS’s News Sentiment?
      100% of articles about ALMS were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week